Bonus & Incentive Agreements
Biotechnology
Biotechnology (4,403) | Bonus & Incentive Agreements (80,626)
- 4D Molecular Therapeutics Inc (8 contracts)
- 89bio, Inc. (1)
- AbbVie Inc. (16)
- ACADIA PHARMACEUTICALS INC (8)
- ACCELERON PHARMA INC (21)
- Accustem Sciences Inc. (1)
- Achaogen, Inc. (14)
- ACHIEVE LIFE SCIENCES, INC. (8)
- Acorda Therapeutics (6)
- Actinium Pharmaceuticals, Inc. (3)
- Acumen Pharmaceuticals, Inc. (2)
- Acurx Pharmaceuticals, LLC (1)
- Adagio Therapeutics, Inc. (4)
- Adamas Pharmaceuticals Inc (8)
- Adhera Therapeutics, Inc. (9)
- ADiTx Therapeutics, Inc. (2)
- ADMA BIOLOGICS, INC. (1)
- ADURO BIOTECH, INC. (11)
- Advaxis, Inc. (1)
- Adverum Biotechnologies, Inc. (13)
- Aeglea BioTherapeutics, Inc. (3)
- Aerovate Therapeutics, Inc. (3)
- AGENUS INC (19)
- AGIOS PHARMACEUTICALS INC (11)
- AILERON THERAPEUTICS INC (11)
- Aimmune Therapeutics, Inc. (4)
- AKCEA THERAPEUTICS, INC. (6)
- Akebia Therapeutics, Inc. (15)
- Akero Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (15)
- Aldeyra Therapeutics, Inc. (8)
- Alector, Inc. (4)
- Alexion Pharmaceuticals (25)
- Aligos Therapeutics, Inc. (8)
- Alkermes plc. (44)
- Allakos Inc. (3)
- Allarity Therapeutics, Inc. (1)
- Allena Pharmaceuticals, Inc. (3)
- Alliqua BioMedical, Inc. (12)
- Allogene Therapeutics, Inc. (2)
- Allovir, Inc. (2)
- ALNYLAM PHARMACEUTICALS, INC. (39)
- Alpha Healthcare Acquisition Corp. (10)
- ALPINE IMMUNE SCIENCES, INC. (8)
- Altimmune, Inc. (11)
- ALX ONCOLOGY HOLDINGS INC (2)
- AMARILLO BIOSCIENCES INC (3)
- AMARIN CORP PLC (14)
- AMERICAN CRYOSTEM Corp (2)
- Amgen Inc. (72)
- AMICUS THERAPEUTICS, INC. (22)
- AmpliPhi Biosciences Corp (3)
- Amplitude Healthcare Acquisition Corp (4)
- ANAPTYSBIO INC (3)
- Anika Therapeutics (17)
- Anixa Biosciences Inc (4)
- Annexon, Inc. (9)
- Annovis Bio, Inc. (3)
- Apellis Pharmaceuticals, Inc. (9)
- APPLIED GENETIC TECHNOLOGIES CORP (9)
- Applied Molecular Transport Inc. (7)
- Applied Therapeutics Inc. (6)
- Aprea Therapeutics, Inc. (2)
- Aptevo Therapeutics Inc. (4)
- AquaBounty Technologies, Inc. (4)
- AQUINOX PHARMACEUTICALS, INC (5)
- Aravive, Inc. (4)
- Arbutus Biopharma Corp (6)
- ARCA biopharma, Inc. (21)
- Arcellx, Inc. (3)
- Arcturus Therapeutics Holdings Inc. (1)
- Arcus Biosciences, Inc. (4)
- Arcutis Biotherapeutics, Inc. (4)
- ARDELYX, INC. (6)
- ARENA PHARMACEUTICALS INC (50)
- ARROWHEAD PHARMACEUTICALS, INC. (6)
- Arsanis, Inc. (25)
- Artiva Biotherapeutics, Inc. (4)
- ARYA Sciences Acquisition Corp II (3)
- ASSEMBLY BIOSCIENCES, INC. (16)
- Atara Biotherapeutics, Inc. (10)
- Athenex, Inc. (4)
- ATHERSYS, INC (24)
- ATOSSA GENETICS INC (10)
- Atreca, Inc. (3)
- aTYR PHARMA INC (7)
- Aura Biosciences, Inc. (3)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (10)
- Avid Bioservices, Inc. (16)
- Avidity Biosciences, Inc. (4)
- AVROBIO, Inc. (4)
- Axcella Health Inc. (4)
- Axovant Sciences Ltd. (7)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (2)
- AzurRx BioPharma, Inc. (1)
- BCTG Acquisition Corp. (3)
- Beam Therapeutics Inc. (8)
- BeiGene, Ltd. (37)
- BELLICUM PHARMACEUTICALS, INC (20)
- Benitec Biopharma Inc. (3)
- BICYCLE THERAPEUTICS Ltd (3)
- BIO-PATH HOLDINGS INC (19)
- bioAffinity Technologies, Inc. (1)
- BioAtla, Inc. (2)
- BioCardia, Inc. (6)
- BIOCEPT INC (7)
- BIOCRYST PHARMACEUTICALS INC (16)
- Biogen Inc. (16)
- Biohaven Pharmaceutical Holding Co Ltd. (5)
- BioLife4D Corp (1)
- BIOMARIN PHARMACEUTICAL INC (12)
- Biomea Fusion, Inc. (6)
- BioRestorative Therapies, Inc. (5)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- Biostage, Inc. (7)
- BIOTIME INC (6)
- BioXcel Therapeutics, Inc. (8)
- Black Diamond Therapeutics, Inc. (3)
- Blue Water Vaccines Inc. (12)
- bluebird bio, Inc. (2)
- Blueprint Medicines Corp (13)
- Bolt Biotherapeutics, Inc. (6)
- Bone Biologics Corp (3)
- BRAINSTORM CELL THERAPEUTICS INC. (5)
- BridgeBio Pharma, Inc. (3)
- C4 Therapeutics, Inc. (3)
- Cabaletta Bio, Inc. (1)
- CALADRIUS BIOSCIENCES, INC. (2)
- Calithera Biosciences, Inc. (6)
- Calyxt, Inc. (19)
- CANCER GENETICS, INC (7)
- Candel Therapeutics, Inc. (2)
- CAPRICOR THERAPEUTICS, INC. (5)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
- Capstone Therapeutics Corp. (8)
- CareDx, Inc. (9)
- Caribou Biosciences, Inc. (11)
- CASI Pharmaceuticals, Inc. (13)
- CASTLE BIOSCIENCES INC (7)
- Castle Creek Biosciences, Inc. (2)
- CATABASIS PHARMACEUTICALS INC (8)
- CATALYST BIOSCIENCES, INC. (29)
- CATALYST PHARMACEUTICALS, INC. (2)
- Celcuity Inc. (9)
- Cell Source, Inc. (3)
- Celldex Therapeutics, Inc. (12)
- Cellectar Biosciences, Inc. (16)
- Cellular Biomedicine Group, Inc. (2)
- Celsion CORP (10)
- Centessa Pharmaceuticals Ltd (1)
- Century Therapeutics, Inc. (2)
- Chanticleer Holdings, Inc. (2)
- Chardan Healthcare Acquisition 2 Corp. (3)
- Chardan Healthcare Acquisition Corp. (1)
- Checkpoint Therapeutics, Inc. (2)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (8)
- CHIMERIX INC (8)
- Cibus Global, Ltd. (1)
- Cidara Therapeutics, Inc. (7)
- CLEVELAND BIOLABS INC (5)
- Clovis Oncology, Inc. (4)
- CM Life Sciences III Inc. (3)
- Codiak BioSciences, Inc. (3)
- CohBar, Inc. (5)
- Coherus BioSciences, Inc. (10)
- Comera Life Sciences Holdings, Inc. (1)
- COMPASS Pathways plc (2)
- Conatus Pharmaceuticals Inc. (9)
- CONCERT PHARMACEUTICALS, INC. (6)
- Consonance-HFW Acquisition Corp. (1)
- Constellation Alpha Capital Corp. (6)
- CONSTELLATION PHARMACEUTICALS INC (5)
- CONTRAFECT Corp (6)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- Cortexyme, Inc. (2)
- Corvus Pharmaceuticals, Inc. (1)
- Crinetics Pharmaceuticals, Inc. (8)
- CRISPR Therapeutics AG (16)
- CTD HOLDINGS INC (1)
- CTI BIOPHARMA CORP (32)
- Cue Biopharma, Inc. (5)
- Cullinan Oncology, LLC (2)
- Curative Biotechnology Inc (8)
- CURIS INC (9)
- Cyclacel Pharmaceuticals, Inc. (8)
- CytoDyn Inc. (11)
- Cytokinetics, Incorporated (11)
- CytomX Therapeutics, Inc. (9)
- CYTORI THERAPEUTICS, INC. (11)
- CYTRX CORP (12)
- Day One Biopharmaceuticals Holding Co LLC (2)
- Decibel Therapeutics, Inc. (10)
- DECIPHER BIOSCIENCES, INC. (2)
- Deciphera Pharmaceuticals, Inc. (11)
- DelMar Pharmaceuticals, Inc. (7)
- Denali Therapeutics Inc. (2)
- Dermavant Sciences Ltd (3)
- Dermira, Inc. (4)
- Design Therapeutics, Inc. (3)
- DiaMedica Therapeutics Inc. (9)
- Dicerna Pharmaceuticals Inc (9)
- Diffusion Pharmaceuticals Inc. (5)
- DYADIC INTERNATIONAL INC (2)
- Dynamics Special Purpose Corp. (2)
- DYNAVAX TECHNOLOGIES CORP (8)
- Dyne Therapeutics, Inc. (9)
- Eagle Pharmaceuticals, Inc. (9)
- Edge Therapeutics, Inc. (8)
- Editas Medicine, Inc. (2)
- Eidos Therapeutics, Inc. (8)
- Eiger BioPharmaceuticals, Inc. (11)
- Elevation Oncology, Inc. (2)
- Eliem Therapeutics, Inc. (5)
- Emerald Bioscience, Inc. (8)
- Emergent BioSolutions Inc. (4)
- Enanta Pharmaceuticals, Inc. (21)
- Enochian Biosciences Inc (3)
- Entasis Therapeutics Holdings Inc. (13)
- Entrada Therapeutics, Inc. (3)
- Environmental Impact Acquisition Corp (1)
- ENZON PHARMACEUTICALS, INC. (4)
- Epizyme, Inc. (13)
- Equillium, Inc. (3)
- Erasca, Inc. (2)
- Esperion Therapeutics, Inc. (4)
- Evelo Biosciences, Inc. (3)
- EVOLUTIONARY GENOMICS, INC. (1)
- EXACT SCIENCES CORP (14)
- Exelixis (31)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (9)
- FENNEC PHARMACEUTICALS INC. (1)
- Fibrocell Science, Inc. (9)
- FIBROGEN INC (3)
- Finch Therapeutics Group, Inc. (2)
- FIVE PRIME THERAPEUTICS INC (13)
- Flex Pharma, Inc. (4)
- Flexion Therapeutics Inc (3)
- FLUOROPHARMA MEDICAL, INC. (1)
- Foghorn Therapeutics Inc. (9)
- Forma Therapeutics Holdings, Inc., (3)
- Fortress Biotech, Inc. (4)
- Forty Seven, Inc. (6)
- Frequency Therapeutics, Inc. (2)
- FS Development Corp. (2)
- FS Development Corp. II (2)
- Fusion Pharmaceuticals Inc. (3)
- G1 Therapeutics, Inc. (6)
- Gain Therapeutics, Inc. (2)
- GALECTIN THERAPEUTICS INC (4)
- Galecto Inc. (3)
- Galera Therapeutics, Inc. (5)
- Gamida Cell Ltd. (1)
- Gemphire Therapeutics Inc. (10)
- Gene Biotherapeutics, Inc. (1)
- GENELUX CORP (7)
- Generation Bio Co. (7)
- GENEREX BIOTECHNOLOGY CORP (1)
- GENOCEA BIOSCIENCES, INC. (14)
- Genprex, Inc. (3)
- GeoVax Labs, Inc. (6)
- GERON CORP (24)
- Gilead Sciences (69)
- Global Blood Therapeutics, Inc. (6)
- GLYCOMIMETICS INC (10)
- Gossamer Bio, Inc. (6)
- Grail, Inc. (3)
- Graphite Bio, Inc. (2)
- Greenwich LifeSciences, Inc. (1)
- Gritstone Oncology, Inc. (8)
- GT Biopharma, Inc. (1)
- GTX INC (16)
- GX Acquisition Corp. (4)
- HALOZYME THERAPEUTICS INC (2)
- Harpoon Therapeutics, Inc. (3)
- HCW Biologics Inc. (4)
- Health Sciences Acquisitions Corp (3)
- HEAT BIOLOGICS, INC. (13)
- HEMISPHERX BIOPHARMA INC (3)
- HERON THERAPEUTICS, INC. (4)
- HilleVax, Inc. (2)
- Hillstream BioPharma Inc. (2)
- HISTOGENICS CORP (9)
- Homology Medicines, Inc. (4)
- HOOKIPA Pharma Inc. (9)
- HUMANIGEN, INC (9)
- iBio, Inc. (3)
- Icosavax, Inc. (3)
- IDEAYA Biosciences, Inc. (8)
- IDERA PHARMACEUTICALS, INC. (25)
- IGM Biosciences, Inc. (5)
- Imago BioSciences, Inc. (7)
- Immix Biopharma, Inc. (2)
- IMMUCELL CORP (16)
- IMMUNE PHARMACEUTICALS INC (2)
- Immuneering Corp (3)
- ImmunoCellular Therapeutics, Ltd. (8)
- IMMUNOGEN INC (34)
- Immunome Inc. (3)
- IMMUNOMEDICS INC (13)
- IMPEL NEUROPHARMA INC (3)
- IN8BIO, INC. (6)
- Incyte (24)
- INFINITY PHARMACEUTICALS, INC. (13)
- Inhibikase Therapeutics, Inc. (5)
- Inhibrx, Inc. (10)
- Inmune Bio, Inc. (5)
- Innovation Pharmaceuticals Inc. (4)
- INOVIO PHARMACEUTICALS, INC. (11)
- Inozyme Pharma, Inc. (5)
- INSMED Inc (35)
- Inspyr Therapeutics, Inc. (1)
- Instil Bio, Inc. (5)
- Intec Parent Inc. (2)
- Intec Pharma Ltd. (1)
- Intellia Therapeutics, Inc. (4)
- INTERCEPT PHARMACEUTICALS, INC. (16)
- INTREXON CORP (22)
- Intrinsic Medicine, Inc. (2)
- Invitae Corp (25)
- IONIS PHARMACEUTICALS INC (6)
- IOVANCE BIOTHERAPEUTICS, INC. (15)
- IRONWOOD PHARMACEUTICALS INC (17)
- Isoray, Inc. (1)
- iTeos Therapeutics, Inc. (2)
- Janux Therapeutics, Inc. (2)
- Jounce Therapeutics, Inc. (4)
- Kadmon Holdings, Inc. (7)
- KalVista Pharmaceuticals, Inc. (3)
- Karuna Therapeutics, Inc. (9)
- Karyopharm Therapeutics Inc. (19)
- KBL MERGER CORP. IV (2)
- Keros Therapeutics, Inc. (6)
- Kezar Life Sciences, Inc. (7)
- Kindred Biosciences, Inc. (8)
- Kiniksa Pharmaceuticals, Ltd. (11)
- Kinnate Biopharma Inc. (3)
- Kiromic Biopharma, Inc. (1)
- Kodiak Sciences Inc. (7)
- Kronos Bio, Inc. (1)
- Krystal Biotech, Inc. (8)
- Kura Oncology, Inc. (5)
- Kymera Therapeutics, Inc. (2)
- LA JOLLA PHARMACEUTICAL CO (4)
- Lantern Pharma Inc. (2)
- LEAP THERAPEUTICS, INC. (2)
- Leisure Acquisition Corp. (3)
- LEXICON PHARMACEUTICALS, INC. (22)
- LianBio (5)
- LifeSci Acquisition Corp. (4)
- Ligand Pharmaceuticals Incorporated (3)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- Locust Walk Acquisition Corp. (5)
- LogicBio Therapeutics, Inc. (7)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (5)
- MACROGENICS INC (7)
- MADRIGAL PHARMACEUTICALS, INC. (1)
- Magenta Therapeutics, Inc. (2)
- MAIA Biotechnology, Inc. (9)
- MANNKIND CORP (4)
- MARIZYME INC (9)
- Marker Therapeutics, Inc. (4)
- MATEON THERAPEUTICS INC (6)
- Matinas BioPharma Holdings, Inc. (1)
- MAXCYTE, INC. (9)
- MEDICINOVA INC (6)
- Medovex Corp. (1)
- MeiraGTx Holdings plc (8)
- MERRIMACK PHARMACEUTICALS INC (2)
- Mersana Therapeutics, Inc. (7)
- Metacrine, Inc. (4)
- Millendo Therapeutics, Inc. (22)
- MiMedx Group, Inc. (34)
- Minerva Neurosciences, Inc. (3)
- MiNK Therapeutics, Inc. (10)
- MIRAGEN THERAPEUTICS, INC. (21)
- Mirati Therapeutics, Inc. (4)
- Mirum Pharmaceuticals, Inc. (8)
- Moderna, Inc. (2)
- Molecular Templates, Inc. (8)
- Momenta Pharmaceuticals, Inc. (28)
- Monopar Therapeutics (6)
- Monte Rosa Therapeutics, Inc. (2)
- Morphic Holding, Inc. (4)
- MUSTANG BIO, INC. (2)
- Myovant Sciences Ltd. (11)
- Myriad Genetics, Inc. (18)
- NantKwest, Inc. (4)
- Natera, Inc. (3)
- NAVIDEA BIOPHARMACEUTICALS, INC. (6)
- NEUROCRINE BIOSCIENCES INC (8)
- NEUROTROPE BIOSCIENCE, INC. (6)
- Neurotrope, Inc. (5)
- NEWLINK GENETICS CORP (14)
- NexImmune, Inc. (6)
- NextCure, Inc. (7)
- Nkarta, Inc. (3)
- NOVAVAX INC (10)
- Novus Therapeutics, Inc. (12)
- NTN BUZZTIME INC (27)
- Nuo Therapeutics, Inc. (5)
- Nurix Therapeutics, Inc. (2)
- Nuvalent, Inc. (3)
- Nuvectis Pharma, Inc. (1)
- Ohr Pharmaceutical Inc (6)
- Olema Pharmaceuticals, Inc. (4)
- Olivia Ventures, Inc. (2)
- Omega Therapeutics, Inc. (2)
- OncoCyte Corp (1)
- Oncorus, Inc. (6)
- ONCOSEC MEDICAL Inc (2)
- OPGEN INC (7)
- Ophthotech Corp. (13)
- Opko Health, Inc. (2)
- ORAGENICS INC (9)
- Orchard Therapeutics plc (2)
- Organicell Regenerative Medicine, Inc. (2)
- Organogenesis Holdings Inc. (2)
- ORGANOVO HOLDINGS, INC. (17)
- Oric Pharmaceuticals, Inc. (4)
- Outlook Therapeutics, Inc. (4)
- Ovid Therapeutics Inc. (10)
- Oyster Point Pharma, Inc. (5)
- PALATIN TECHNOLOGIES INC (10)
- Pasithea Therapeutics Corp. (1)
- Passage BIO, Inc. (2)
- PDL BIOPHARMA, INC. (24)
- PepGen Inc. (2)
- Pfenex Inc. (7)
- PharmaCyte Biotech, Inc. (1)
- PhaseBio Pharmaceuticals Inc (5)
- Phio Pharmaceuticals Corp. (5)
- PIERIS PHARMACEUTICALS, INC. (9)
- PMV Pharmaceuticals, Inc. (5)
- POLARITYTE, INC. (22)
- PORTOLA PHARMACEUTICALS INC (11)
- Poseida Therapeutics, Inc. (5)
- Praxis Precision Medicines, Inc. (9)
- PRECISION BIOSCIENCES INC (4)
- Prelude Therapeutics Inc (2)
- Prevail Therapeutics Inc. (2)
- Principia Biopharma Inc. (4)
- Progenics Pharmaceuticals, Inc. (8)
- PROGENITY, INC. (6)
- Prometheus Biosciences, Inc. (3)
- ProMIS Neurosciences Inc. (1)
- Propanc Biopharma, Inc. (1)
- Protagenic Therapeutics, Inc. (3)
- Protagonist Therapeutics, Inc (2)
- Protalix BioTherapeutics, Inc. (3)
- PROTEON THERAPEUTICS INC (7)
- PROTEOSTASIS THERAPEUTICS, INC. (6)
- Prothena Corp plc (24)
- ProtoKinetix, Inc. (5)
- PTC THERAPEUTICS, INC. (18)
- PUMA BIOTECHNOLOGY, INC. (10)
- Pyxis Oncology, Inc. (2)
- Q BioMed Inc. (1)
- Radius Health, Inc. (16)
- Rallybio Corp (7)
- RAPT Therapeutics, Inc. (3)
- Rasna Therapeutics Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (3)
- Regeneron Pharmaceuticals (36)
- REGENERX BIOPHARMACEUTICALS INC (4)
- REGENXBIO Inc. (6)
- Regulus Therapeutics Inc. (6)
- Relay Therapeutics, Inc. (2)
- Reneo Pharmaceuticals, Inc. (8)
- RenovaCare, Inc. (4)
- RenovoRx, Inc. (6)
- Repare Therapeutics Inc. (3)
- Replimune Group, Inc. (1)
- Retrophin, Inc. (8)
- Revolution Medicines, Inc. (6)
- REXAHN PHARMACEUTICALS, INC. (6)
- Rezolute, Inc. (1)
- RHYTHM PHARMACEUTICALS, INC. (3)
- RIGEL PHARMACEUTICALS INC (33)
- RITTER PHARMACEUTICALS INC (8)
- ROCKET PHARMACEUTICALS, INC. (9)
- Rubius Therapeutics, Inc. (3)
- Sage Therapeutics, Inc. (3)
- Sana Biotechnology, Inc. (12)
- SANGAMO THERAPEUTICS, INC (9)
- SANGUI BIOTECH INTERNATIONAL INC (1)
- Sarepta Therapeutics, Inc. (29)
- Savara Inc (41)
- Scholar Rock Holding Corp (1)
- SEATTLE GENETICS INC (74)
- SELECTA BIOSCIENCES INC (3)
- SELLAS Life Sciences Group, Inc. (13)
- Sensei Biotherapeutics, Inc. (2)
- SERA PROGNOSTICS, INC. (3)
- Seres Therapeutics, Inc. (3)
- Sesen Bio, Inc. (14)
- Shattuck Labs, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sierra Oncology, Inc. (3)
- Sigilon Therapeutics, Inc. (7)
- Silverback Therapeutics, Inc. (3)
- Social Capital Suvretta Holdings Corp. III (2)
- SOLENO THERAPEUTICS INC (6)
- Solid Biosciences Inc. (13)
- SOLIGENIX, INC. (7)
- Sorrento Therapeutics, Inc. (5)
- Spectrum Pharmaceuticals, Inc. (18)
- Spero Therapeutics, Inc. (14)
- SPHERIX INC (3)
- Spinning Eagle Acquisition Corp. (2)
- Spring Bank Pharmaceuticals, Inc. (14)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (6)
- SQZ Biotechnologies Co (3)
- Stellar Biotechnologies, Inc. (3)
- Stoke Therapeutics, Inc. (3)
- Sun BioPharma, Inc. (5)
- SUNESIS PHARMACEUTICALS INC (27)
- Surface Oncology, Inc. (8)
- SUTRO BIOPHARMA, INC. (3)
- Syndax Pharmaceuticals Inc (8)
- SYNLOGIC, INC. (10)
- Syros Pharmaceuticals, Inc. (8)
- T2 Biosystems, Inc. (3)
- Talaris Therapeutics, Inc. (3)
- Taysha Gene Therapies, Inc. (3)
- TCR2 THERAPEUTICS INC. (3)
- TENAX THERAPEUTICS, INC. (9)
- Tenaya Therapeutics, Inc. (4)
- TG THERAPEUTICS, INC. (2)
- Therapeutics Acquisition Corp. (9)
- Tocagen Inc (7)
- Tracon Pharmaceuticals, Inc. (7)
- Transcode Therapeutics, Inc. (2)
- Translate Bio, Inc. (10)
- TREVENA INC (7)
- TScan Therapeutics, Inc. (3)
- Turning Point Therapeutics, Inc. (3)
- Twist Bioscience Corp (2)
- TYME TECHNOLOGIES, INC. (3)
- Tyra Biosciences, Inc. (2)
- Ultragenyx Pharmaceutical Inc. (16)
- Unicycive Therapeutics, Inc. (2)
- uniQure N.V. (11)
- United Therapeutics Corp (20)
- Unity Biotechnology, Inc. (7)
- Unum Therapeutics Inc. (5)
- UroGen Pharma Ltd. (5)
- VACCINEX, INC. (3)
- Vaccitech plc (1)
- Vanda Pharmaceuticals Inc. (8)
- Vaxart, Inc. (10)
- Vaxcyte, Inc. (2)
- Vaxxinity, Inc. (4)
- VBI Vaccines Inc (1)
- Vera Therapeutics, Inc. (5)
- VERACYTE, INC. (6)
- Verastem, Inc. (21)
- Vericel Corp (27)
- Vertex Pharmaceuticals Inc (1)
- Verve Therapeutics, Inc. (7)
- VICAL INC (14)
- Viela Bio, Inc. (2)
- Vigil Neuroscience, Inc. (3)
- Viking Therapeutics, Inc. (7)
- Vir Biotechnology, Inc. (7)
- Virios Therapeutics, LLC (2)
- VistaGen Therapeutics, Inc. (5)
- VITAL THERAPIES INC (8)
- VITRO DIAGNOSTICS INC (4)
- Vor Biopharma Inc. (2)
- Voyager Therapeutics, Inc. (1)
- vTv Therapeutics Inc. (3)
- Werewolf Therapeutics, Inc. (7)
- WINDTREE THERAPEUTICS INC (12)
- XBiotech Inc. (4)
- Xencor Inc (4)
- Xenetic Biosciences, Inc. (1)
- Xenon Pharmaceuticals Inc. (5)
- Xilio Therapeutics, Inc. (9)
- XOMA Corp (11)
- Y-mAbs Therapeutics, Inc. (8)
- YIELD10 BIOSCIENCE, INC. (9)
- ZAFGEN, INC. (4)
- Zai Lab Ltd (1)
- Zentalis Pharmaceuticals, LLC (5)
- ZIOPHARM ONCOLOGY INC (10)
- Zymeworks Inc. (1)
- Amendment No. 3 to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (AquaBounty Technologies, Inc., Filed With SEC on May 26, 2023)
- Amendment No. 2 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan (Stellar Biotechnologies, Inc., Filed With SEC on May 24, 2023)
- Fourth Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan (Prothena Corp plc, Filed With SEC on May 19, 2023)
- aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (aTYR PHARMA INC, Filed With SEC on May 19, 2023)
- Form of Performance Unit Agreement (XOMA Corp, Filed With SEC on May 18, 2023)
- Inovio Pharmaceuticals, Inc. 2023 Omnibus Incentive Plan (INOVIO PHARMACEUTICALS, INC., Filed With SEC on May 18, 2023)
- Calyxt, Inc. 2023 Short Term Incentive Plan (Calyxt, Inc., Filed With SEC on May 17, 2023)
- Form of Performance Stock Unit Agreement (Calyxt, Inc., Filed With SEC on May 17, 2023)
- Amendment to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan (Celcuity Inc., Filed With SEC on May 12, 2023)
- 2018 Employee, Director and Consultant Equity Incentive Plan, effective as of March 28, 2019 (Diffusion Pharmaceuticals Inc., Filed With SEC on May 11, 2023)
- Retention Bonus (Instil Bio, Inc., Filed With SEC on May 11, 2023)
- Retention Bonus Agreement, by and between the Registrant and Bronson Crouch, dated as of February 22, 2023 (Instil Bio, Inc., Filed With SEC on May 11, 2023)
- Amended and Restated 2019 Stock Option and Incentive Plan (HOOKIPA Pharma Inc., Filed With SEC on May 11, 2023)
- Form of RSU Agreement pursuant to the OnkosXcel Therapeutics, LLC and OnkosXcel Employee Holdings, LLC Management Incentive Plan (BioXcel Therapeutics, Inc., Filed With SEC on May 9, 2023)
- Second Amended and Restated 2022 Inducement Equity Incentive Plan (Constellation Alpha Capital Corp., Filed With SEC on May 9, 2023)
- Invitae Corporation 2015 Stock Incentive Plan, as amended and restated as of April 3, 2023 (Invitae Corp, Filed With SEC on May 9, 2023)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the 2017 IPO Stock Incentive Plan (Krystal Biotech, Inc., Filed With SEC on May 8, 2023)
- Form of Time-Based Restricted Stock Unit Award Agreement under the 2017 IPO Stock Incentive Plan (Krystal Biotech, Inc., Filed With SEC on May 8, 2023)
- Bonus Agreement, made and entered into as of May 1, 2023, by and between Dominari Holdings Inc. and Matthew B. McCullough (SPHERIX INC, Filed With SEC on May 5, 2023)
- Form of Restricted Stock Unit Agreement under the 2017 Equity Incentive Plan (Employee) (Myriad Genetics, Inc., Filed With SEC on May 4, 2023)
- First Amendment to the Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan (Regeneron Pharmaceuticals, Filed With SEC on May 4, 2023)
- Form of Restricted Stock Unit Agreement pursuant to AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (AquaBounty Technologies, Inc., Filed With SEC on May 4, 2023)
- Fourteenth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (Prothena Corp plc, Filed With SEC on May 4, 2023)
- Form of Restricted Stock Unit Award Agreement for Executive Officers under 2018 Stock Incentive Plan, as amended (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on May 4, 2023)
- Form of Performance Stock Unit Award Agreement for Executive Officers under 2018 Stock Incentive Plan, as amended (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on May 4, 2023)
- Global restricted stock unit issuance agreement for Deborah Telman under 2022 Equity Incentive Plan (4 year vest) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Global restricted stock unit issuance agreement for Deborah Telman under 2022 Equity Incentive Plan (3 year vest) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Global stock option agreement for Deborah Telman under 2022 Equity Incentive Plan (Gilead Sciences, Filed With SEC on May 3, 2023)
- Form of global employee restricted stock unit agreement under 2022 Equity Incentive Plan (4 year vest) (for grants commencing in 2023) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Form of performance share award agreement - Revenue Goals (U.S.) under 2022 Equity Incentive Plan (for grants commencing in 2023) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Form of performance share award agreement - TSR Goals (U.S.) under 2022 Equity Incentive Plan (for grants commencing in 2023) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Form of global employee stock option agreement under 2022 Equity Incentive Plan (4 year vest) (for certain grants commencing in 2023) (Gilead Sciences, Filed With SEC on May 3, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Inventive Plan (Deciphera Pharmaceuticals, Inc., Filed With SEC on May 3, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Company Employees under 2017 Stock Option and Inventive Plan (Deciphera Pharmaceuticals, Inc., Filed With SEC on May 3, 2023)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the Amended and Restated 2017 Employee, Director and Consultant Equity Plan (G1 Therapeutics, Inc., Filed With SEC on May 3, 2023)
- Form of Restricted Stock Unit Award Agreement for Employees under the Amended and Restated 2016 Equity Incentive Plan (Vanda Pharmaceuticals Inc., Filed With SEC on May 3, 2023)
- Form of Restricted Stock Unit Award Agreement for Executive Officers under the Amended and Restated 2016 Equity Incentive Plan (Vanda Pharmaceuticals Inc., Filed With SEC on May 3, 2023)
- 2017 Non-Employee Directors Equity Incentive Plan, as amended (LEXICON PHARMACEUTICALS, INC., Filed With SEC on April 27, 2023)
- 2017 Equity Incentive Plan, as amended (LEXICON PHARMACEUTICALS, INC., Filed With SEC on April 27, 2023)
- Form of Option Award under the 2016 Omnibus Incentive Compensation Plan, as amended and restated (Nuo Therapeutics, Inc., Filed With SEC on April 17, 2023)